A $14 billion U.S. arms package for Taiwan has remained stalled for months, and Anduril founder Palmer Luckey said Saturday that the delay is already affecting the defense-technology company’s business. In comments reported by Reuters, Luckey said he had discussed the issue with President Donald Trump, Vice President JD Vance and Secretary of State Marco Rubio, but did not identify which Anduril programs or contract values were being held up.

The disclosure turns a geopolitical dispute into a concrete commercial risk for one of the most closely watched U.S. defense startups. It does not show that Anduril has lost an award, nor that the entire package is tied to the company. It does show that uncertainty at the presidential-approval stage can interrupt work beyond a single sale, including planning, supplier commitments and follow-on cooperation.

Delay becomes a company problem

Luckey said Anduril’s business with Taiwan “would be in a different place” if the package were moving forward. He also argued that a stalled package can impede progress in other areas, an important distinction for a company whose model depends on moving relatively low-cost autonomous systems from development into production faster than traditional weapons programs.

The package cannot proceed until Trump formally submits it to Congress. Taiwan said earlier this year that Washington had not notified it of a formal cancellation, while the Associated Press reported that administration officials described foreign military sales as paused while the United States prioritized munitions for its Iran campaign. That leaves the commercial status in an unusually ambiguous position: approved in Taiwan’s political process, but not advanced through the U.S. executive step needed for congressional review.

Anduril’s Taiwan strategy is broader than one order

Anduril already has equipment in Taiwan and is building a deeper industrial relationship there. The company’s Altius drone is used by the island’s military, according to Reuters, and Taiwan last year displayed the Barracuda-500, an autonomous cruise missile designed by Anduril. Taiwan’s state-run National Chung-Shan Institute of Science and Technology said it planned to produce the system locally through technology transfer, according to earlier reporting.

That arrangement helps explain why Luckey emphasized spillover rather than only the value of a delayed sale. Local production requires technical coordination, factory preparation, testing schedules and supplier decisions that can be difficult to separate from the broader political relationship. Anduril says the surface-launched Barracuda-500 is intended to give ground forces a mass-producible, long-range autonomous system. The company’s description is a product claim, not independent proof of cost or battlefield performance, but it shows the industrial proposition Anduril is bringing to Taiwan.

A fast-growing market meets presidential leverage

Taiwan is increasing defense spending and placing drones at the center of its modernization effort. On Friday, its military conducted its first joint combat drills combining several types of attack drones with conventional weapons, the AP reported. Those exercises underscore the demand opportunity for suppliers such as Anduril, but they also show why the transactions are politically sensitive before Trump meets Chinese President Xi Jinping next week.

Trump has called the Taiwan package a negotiating chip in talks with China. Beijing opposes U.S. weapons sales to the island and has used sanctions against American defense companies and executives, including Luckey. For Anduril, the result is a two-sided exposure: Washington controls whether a sale advances, while Beijing can raise the cost of participation through sanctions or pressure on critical-material supply chains. Luckey acknowledged that administration officials were weighing possible Chinese retaliation involving rare earths used by technology companies.

The size of Anduril’s exposure remains unknown

The $14 billion headline figure should not be read as Anduril revenue. Neither the White House nor Anduril has publicly broken out the company’s share of the package, and Luckey declined to specify what business was delayed. The most defensible conclusion is narrower: the company says the pause is constraining its Taiwan work, but investors, suppliers and policymakers cannot yet quantify the financial effect.

That limitation matters because defense contracting revenue is recognized through particular awards, milestones and deliveries, not broad political packages. A delayed authorization may push expected work into a later period without eliminating it, or it may change the mix of products, contractors and local manufacturing. Until the administration submits the package and the contracts become identifiable, claims about lost sales or profit would be speculative.

The next signal will come from Washington

Congress has repeatedly reaffirmed the policy of providing Taiwan with defensive arms. A bipartisan Senate Foreign Relations Committee resolution introduced in May said the Taiwan Relations Act and the “Six Assurances” remain foundations of the relationship, including the principle that Washington did not agree to consult Beijing before selling arms to Taiwan. That support, however, does not substitute for the executive action required to move this package.

For Anduril, the decisive event is therefore not another product announcement but a change in the package’s legal and political status. Saturday’s comments establish that the delay has moved beyond diplomatic signaling and into company operations. They do not establish the size or duration of the damage. The next measurable evidence will be a formal submission, a revised package, disclosed contracts or a continued hold after the Trump-Xi meeting.